![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, June 14, 2019 2:20:12 PM
What Simps is pointing out is the complete lack of progression do to AW's constant blundering, and basically being handed deal after deal and refusing to take any of them. BIEL is a small biotech company, that has to sell shares to keep operating, that is something that is not sustainable! It will increase the dilution, which will further suppress the the stock price. Without a partner with deep pockets and brand awareness, it will be impossible for this stock to have any kind of sustained run or even get out of sub-penny, and that's with full FDA approval. And BIEL itself could go bankrupt as well.
So yes BIEL can sell a few Actipatches here a there, but without some kind of major deal or partnership, those sales really won't matter!
FEATURED Element79 Gold Corp Provides Update on Nevada Portfolio • Aug 23, 2024 8:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM